NOV 12, 2015 02:47 PM PST

Regulating the Immune Response to Relieve IBD Symptoms

WRITTEN BY: Kara Marker
Scientists from the Beth Israel Deaconess Medical Center (BIDMC) have been studying immune action in cases of inflammatory bowel disease (IBD) for more than ten years. This week, they discovered a connection between immune cells and cytokine signaling that could change the way people live with IBD. 

According to the CDC, common types of IBD like Crohn's disease and ulcerative colitis affect more than a million Americans. These diseases are characterized by chronic inflammation of the gastrointestinal (GI) tract due to an unwarranted immune response. The immune cells act as if normal compounds in the GI tract are foreign and dangerous. 

The basic premise of IBD involves the unregulated action of effector immune cells in the GI tract; cytokines are released and stimulate inflammation of the bowels even though no pathogens or damages are present. The scientists from the BIDMC study the two immune cells involved in the troubling IBD immune response: CD4 T cells and Type 1 CD8+ T cells (TC1).

Specifically in Crohn's disease, TC1 cells produce interferon gamma, a cytokine that induces inflammation. Normally, regulatory immune cells inhibit the action of TC1 cells when no action is required, but Crohn's disease patients are chronically unable to perform this maintainence. To make up for this malfunction, the scientists looked at the expression of CD39, an ectoenzyme, on TC1 to see if they could halt the overproduction of interferon gamma.

Ectoenzymes like CD39 have their enzymatically active site outside the plasma membrane, in the extracellular environment. CD39 is naturally expressed by dendritic cells and some regulatory cells and acts as an immunosuppressive.

CD39 is able to regulate the autoimmune reactions in Crohn's disease through "catalytic conversion of proinflammatory extracelluar ATP to immunosuppressive nucleosides" like adenoside, a behavior used by the BIDMC scientists over the past decade as they looked for a way to counter the effect of IBD. Essentially, this enzyme transforms the energy produced by the GI tract inflammation into a product that suppresses the inflammation. 

To conclude their study, the scientists from BIDMC were able to put all of the pieces together by discovering that upregulation of CD39 in IBD patients helped suppress and inhibit interferon gamma production in neighboring TC1 cells. This connection leads to promising new treatment plans for IBD patients, manipulating the body's natural way of controlling inflammation.

Check out the video below to learn more about Crohn's disease and how inflammation of the GI tract affects digestion. 

Source: Medical Xpress



 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 27, 2018
Immunology
NOV 27, 2018
A Mutated Immunity
Researchers utilize blood samples to determine cancer neoantigens to create effective vaccination in mouse model...
NOV 30, 2018
Microbiology
NOV 30, 2018
C-Section Deliveries Disrupt the Transmission of Microbes From Mom to Baby
From our earliest days, bacteria exert a powerful influence on many aspects of our health....
DEC 04, 2018
Immunology
DEC 04, 2018
Natural HIV Resistance
A team of scientists discover unique immune reactions to the one percent of HIV infected patients that are able to fend off viral propagation without antiretroviral therapy...
DEC 19, 2018
Immunology
DEC 19, 2018
UTI Infection Becoming a Common Reoccurrence?
Researchers have shed new light on the connection between recurring urinary tract infections and the bacterial strain involved...
DEC 26, 2018
Immunology
DEC 26, 2018
When the Immune System Makes a Mistake: Autoimmunity
A team from Scripps Research has found a molecular cause of a group of rare autoimmune disorders in which the immune system attacks the body's healthy cells....
FEB 20, 2019
Immunology
FEB 20, 2019
Silent Inflammation, the Silent Problem
People who have chronic inflammation in middle-age may develop problems with thinking and memory...
Loading Comments...